Study of the Validity and Reliability of Two Digital Dynamometers in Older People
Launched by UNIVERSITY OF SALAMANCA · Sep 29, 2024
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two special devices that measure grip strength and how quickly muscles get tired in older adults who live at home. Grip strength is important because it can tell us a lot about a person's overall health, especially as they age. The study will last for six months and aims to ensure that these devices work well and provide accurate results for people over 60 years old.
To be part of this study, participants need to be healthy older adults who can follow simple instructions. However, people with certain conditions, like severe dementia or recent hand pain, won't be eligible. If you join the study, you'll be helping researchers understand how to better measure muscle strength in older adults, which can lead to better care and support for this age group in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Community-dwelling older adults of both sexes over 60 years of age.
- Exclusion Criteria:
- • Those who do not understand the orders given to them by the researcher or present an obvious advanced state of dementia.
- • Those people who have amputation in one of the two upper limbs or who cannot perform manual grasping for any reason.
- • Those who have had an episode of pain in one of the hands during the week prior to the measurement.
- • Those who, due to any illness, prevent or contraindicate maximum resistance exercises.
- • Any other cause that the research team assesses that may affect the results.
About University Of Salamanca
The University of Salamanca, one of the oldest and most prestigious universities in Spain, is a leading institution in academic research and clinical trials. With a strong commitment to advancing healthcare and medical science, the university engages in innovative research initiatives that address critical health challenges. Its clinical trial programs are characterized by rigorous scientific methodology, interdisciplinary collaboration, and a focus on ethical standards, ensuring high-quality outcomes that contribute to the advancement of medical knowledge and patient care. The University of Salamanca fosters partnerships with healthcare professionals and industry leaders, positioning itself at the forefront of clinical research and education.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salamanca, , Spain
Patients applied
Trial Officials
Luis Polo-Ferrero, PhD
Principal Investigator
University of Salamanca
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported